Related references
Note: Only part of the references are listed.The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption
Hironobu Yasui et al.
BMC CANCER (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Exploiting the Cancer Genome: Strategies for the Discovery and Clinical Development of Targeted Molecular Therapeutics
Timothy A. Yap et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Studying a Complex Tumor Potential and Pitfalls
Siyuan Zheng et al.
CANCER JOURNAL (2012)
Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In Vivo
Isaac Marin-Valencia et al.
CELL METABOLISM (2012)
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
Liuqi Yang et al.
EXPERIMENTAL CELL RESEARCH (2012)
Passenger deletions generate therapeutic vulnerabilities in cancer
Florian L. Muller et al.
NATURE (2012)
High-Resolution In-Vivo Analysis of Normal Brain Response to Cranial Irradiation
Kelly Burrell et al.
PLOS ONE (2012)
Cancer Cell Metabolism: One Hallmark, Many Faces
Jason R. Cantor et al.
CANCER DISCOVERY (2012)
AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
O. L. Chinot et al.
ADVANCES IN THERAPY (2011)
Heterogeneity Maintenance in Glioblastoma: A Social Network
Rudy Bonavia et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Metabolism and Brain Cancer
Suely Kazue Nagahashi Marie et al.
CLINICS (2011)
Stromal-epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironment
Ubaldo E. Martinez-Outschoorn et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Charting the course across the blood-brain barrier
David Nathanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Angioarchitectural heterogeneity in human glioblastoma multiforme: A fractal-based histopathological assessment
Antonio Di Ieva et al.
MICROVASCULAR RESEARCH (2011)
Molecular targeting of glioblastoma: Drug discovery and therapies
Ren-Yuan Bai et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Metabolic Targeting of Lactate Efflux by Malignant Glioma Inhibits Invasiveness and Induces Necrosis: An In Vivo Study
Chaim B. Colen et al.
NEOPLASIA (2011)
A Phase 2 Trial of Single-Agent Bevacizumab Given in an Every-3-Week Schedule for Patients With Recurrent High-Grade Gliomas
Jeffrey J. Raizer et al.
CANCER (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway
Min Fang et al.
CELL (2010)
The reverse Warburg effect Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts
Gloria Bonuccelli et al.
CELL CYCLE (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
S. Ganapathy-Kanniappan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Angioarchitectural morphometrics of brain tumors: Are there any potential histopathological biomarkers?
Antonio Di Ieva
MICROVASCULAR RESEARCH (2010)
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Frederic G. Dhermain et al.
LANCET NEUROLOGY (2010)
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
John F. de Groot et al.
NEURO-ONCOLOGY (2010)
Role of Angiopoietin-2 in Regulating Growth and Vascularity of Astrocytomas
Gelareh Zadeh et al.
JOURNAL OF ONCOLOGY (2010)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling
Chendong Yang et al.
CANCER RESEARCH (2009)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
Novel Imaging Provides New Insights into Mechanisms of Oxygen Transport in Tumors
Matthew E. Hardee et al.
CURRENT MOLECULAR MEDICINE (2009)
Glioblastoma multiforme: a review of where we have been and where we are going
Cory Adamson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
R. M. Zuniga et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model
E. M. Hendriksen et al.
MICROVASCULAR RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Bevacizumab plus irinotecan in recurrent glioblastoma
Marc C. Chamberlain
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intravascular thrombosis in central nervous system malignancies: A potential role in astrocytoma progression to glioblastoma
Mahtab Tehrani et al.
BRAIN PATHOLOGY (2008)
Hypoxia, DNA repair and genetic instability
Robert G. Bristow et al.
NATURE REVIEWS CANCER (2008)
Tumour vascularization: sprouting angiogenesis and beyond
Femke Hillen et al.
CANCER AND METASTASIS REVIEWS (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1α in human glioma in vitro and in vivo
Harun M. Said et al.
RADIOTHERAPY AND ONCOLOGY (2007)
2-Deoxy-D-glucose combined with cisplatin, enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells
Andreart L. Simons et al.
CANCER RESEARCH (2007)
Design of hypoxia-targeting drugs as new cancer chemotherapeutics
Hideko Nagasawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Angiogenic patterns and their quantitation in high grade astrocytic tumors
Suash Sharma et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Role of efaproxiral in metastatic brain tumors
Ryon H. Engel et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Yuan Rong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
ATP citrate lyase is an important component of cell growth and transformation
DE Bauer et al.
ONCOGENE (2005)
Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines
CE Griguer et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding
SM Evans et al.
CANCER RESEARCH (2004)
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population
DJ Brat et al.
CANCER RESEARCH (2004)
Lactate in solid malignant tumors: Potential basis of a metabolic classification in clinical oncology
S Walenta et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Hypoxia is important in the biology and aggression of human glial brain tumors
SM Evans et al.
CLINICAL CANCER RESEARCH (2004)
Lactate: Mirror and motor of tumor malignancy
S Walenta et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
YH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Angiogenic factors in the central nervous system
MR Harrigan
NEUROSURGERY (2003)
Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. (vol 138, pg 659, 2003)
DJ Brat et al.
ANNALS OF INTERNAL MEDICINE (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme
S Oudard et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Malignant glioma physiology: Cellular response to hypoxia and its role in tumor progression
DJ Brat et al.
ANNALS OF INTERNAL MEDICINE (2003)
Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins:: Evidence for distinct angiogenic subtypes
P Birner et al.
BRAIN PATHOLOGY (2003)
Angiogenesis in nervous system disorders
G Zadeh et al.
NEUROSURGERY (2003)
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes
DC Berwick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells
ML Turcotte et al.
BRITISH JOURNAL OF CANCER (2002)
Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms
P Korkolopoulou et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
JM Brown
MOLECULAR MEDICINE TODAY (2000)
Share Paper
